Naproxen Suspension
Product Images NDC 0054-3630

2 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Naproxen (NDC 0054-3630). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle (Image 01)

Bottle (Image 01)
Naproxen Oral Suspension, USP 125 mg per 5 mL label with a 500 mL volume, distributed by Hikma Pharmaceuticals USA Inc. The label includes usage instructions such as shaking gently before use and storage conditions at 20° to 25°C. It also features a barcode and emphasizes that the accompanying Medication Guide must be dispensed with the product.*
FDA Label Image

Naproxen-chem.jpg (Naproxen Chem)

Naproxen-chem.jpg (Naproxen Chem)
Chemical structure of naproxen, the active ingredient in Naproxen 125 mg/5mL oral suspension by Hikma Pharmaceuticals USA Inc. The diagram shows the molecular arrangement including the methoxy group (CH3O) and carboxyl (CO2H) functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.